Papaverine Hydrochloride (American Regent, Inc.)


Welcome to the PulseAid listing for the Papaverine Hydrochloride drug offered from American Regent, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: American Regent, Inc.
NON-PROPRIETARY NAME: Papaverine Hydrochloride
SUBSTANCE NAME: PAPAVERINE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 1995-09-01
END MARKETING DATE: 0000-00-00


Papaverine Hydrochloride HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPapaverine Hydrochloride from American Regent, Inc.
LABELER NAME: American Regent, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 30(mg/mL)
START MARKETING DATE: 1995-09-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0517-4002_ac8f5e38-3e5b-4879-8d91-125a781e364f
PRODUCT NDC: 0517-4002
APPLICATION NUMBER:

Other PAPAVERINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
American Regent, Inc.Papaverine Hydrochloride